...
首页> 外文期刊>Ophthalmology >Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications.
【24h】

Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications.

机译:连续100例虹​​膜肿瘤细针穿刺活检:技术和并发症。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To evaluate the technique and complications of fine-needle aspiration biopsy (FNAB) for iris tumors. DESIGN: Retrospective, nonrandomized, single-center case series. PARTICIPANTS: One hundred eyes of 100 patients with diagnostically challenging iris tumors evaluated with FNAB. MAIN OUTCOME MEASURES: Biopsy technique and complications. RESULTS: Of more than 1400 patients referred with an iris tumor over a 24-year period, 100 underwent FNAB for diagnostic purposes. The median patient age was 44 years. The median basal dimension of the lesion was 9.0 mm and median thickness was 2.5 mm. A limbal entry with transaqueous approach parallel to the iris was used in 100% of patients. Entry was from the superotemporal (52%) or inferotemporal (42%) direction. Needle gauge size was 22 (9%), 25 (55%), 27 (25%), or 30 (9%), depending on the friability and vascularity of the tumor. Adequate tumor sample was achieved in 99 eyes (99%). At the time of FNAB, the only immediate complication was partial hyphema (34%). Two weeks after FNAB, persistent hyphema was found in 6 eyes (6%), requiring surgical washout in 1 patient. There were no cases of recurrent hyphema, vitreous hemorrhage, prolonged hypotony, lens damage, endophthalmitis, or extraocular tumor seeding. At mean follow-up of 5 years, there was no incident of tumor recurrence on the iris, along the needle tract, or on the corneal or epibulbar surface. CONCLUSIONS: Using our technique, FNAB for diagnostically challenging iris tumors can achieve high yield with relatively few complications.
机译:目的:评估虹膜肿瘤细针穿刺活检的技术及并发症。设计:回顾性,非随机,单中心案例系列。参与者:用FNAB评估的100例具有诊断挑战性虹膜肿瘤的患者的一百只眼。主要观察指标:活检技术及并发症。结果:在24年的时间里,有1400例虹膜肿瘤转诊患者,其中100例接受了FNAB诊断。患者的中位年龄为44岁。病变的中位基底尺寸为9.0 mm,中位厚度为2.5 mm。 100%的患者采用与虹膜平行的透水入路角膜缘入路。进入时间从颞上颞(52%)或​​颞下颞(42%)方向开始。针规大小为22(9%),25(55%),27(25%)或30(9%),具体取决于肿瘤的易碎性和血管性。在99只眼中获得了足够的肿瘤样本(99%)。在进行FNAB手术时,唯一的直接并发症是部分性前房积血(34%)。 FNAB后两周,在6眼(6%)中发现了持续性前房积血,需要对1例患者进行手术冲洗。没有复发性前房积血,玻璃体出血,长时间低渗,晶状体损伤,眼内炎或眼外肿瘤播种的病例。在平均5年的随访中,虹膜,沿针道,角膜或表皮表面未见肿瘤复发。结论:使用我们的技术,FNAB可用于诊断具有挑战性的虹膜肿瘤,并能获得相对较少并发症的高产率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号